| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Polyomavirus Infections | 5 | 2019 | 156 | 1.75 | Why? |
| BK Virus | 4 | 2019 | 135 | 1.61 | Why? |
| Encephalitis, Tick-Borne | 2 | 2017 | 86 | 1.28 | Why? |
| Kidney Transplantation | 12 | 2021 | 5397 | 1.02 | Why? |
| Heterocyclic Compounds, 3-Ring | 3 | 2018 | 275 | 0.86 | Why? |
| Tumor Virus Infections | 2 | 2019 | 127 | 0.81 | Why? |
| HIV Integrase Inhibitors | 2 | 2019 | 173 | 0.79 | Why? |
| DNA, Viral | 4 | 2018 | 2521 | 0.76 | Why? |
| Torque teno virus | 1 | 2019 | 73 | 0.74 | Why? |
| DNA Virus Infections | 1 | 2019 | 88 | 0.73 | Why? |
| Polyomavirus | 1 | 2018 | 37 | 0.72 | Why? |
| Human T-lymphotropic virus 2 | 1 | 2017 | 8 | 0.70 | Why? |
| Viremia | 4 | 2019 | 1020 | 0.69 | Why? |
| HTLV-I Infections | 1 | 2017 | 54 | 0.66 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2017 | 100 | 0.65 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 7868 | 0.64 | Why? |
| HIV-1 | 8 | 2020 | 3365 | 0.64 | Why? |
| Pharmacy Residencies | 1 | 2017 | 59 | 0.63 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.62 | Why? |
| Medical Laboratory Science | 1 | 2017 | 122 | 0.61 | Why? |
| France | 21 | 2021 | 12074 | 0.61 | Why? |
| Anti-HIV Agents | 5 | 2020 | 2209 | 0.53 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.51 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.49 | Why? |
| Serologic Tests | 4 | 2021 | 4359 | 0.49 | Why? |
| Virology | 1 | 2017 | 489 | 0.49 | Why? |
| Problem-Based Learning | 1 | 2017 | 363 | 0.46 | Why? |
| HIV Infections | 9 | 2020 | 11620 | 0.44 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.41 | Why? |
| Viral Load | 10 | 2021 | 15850 | 0.41 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.40 | Why? |
| Kidney Diseases | 2 | 2019 | 1434 | 0.39 | Why? |
| Graft Rejection | 2 | 2019 | 1766 | 0.39 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.38 | Why? |
| Immunoglobulin M | 4 | 2021 | 9091 | 0.38 | Why? |
| Drug Resistance, Multiple, Viral | 2 | 2019 | 37 | 0.37 | Why? |
| Brain Diseases | 4 | 2021 | 1463 | 0.36 | Why? |
| Lymphocytic Choriomeningitis | 2 | 2017 | 43 | 0.35 | Why? |
| Oxazines | 3 | 2018 | 279 | 0.35 | Why? |
| Drug Resistance, Viral | 3 | 2020 | 1083 | 0.35 | Why? |
| Personal Satisfaction | 1 | 2017 | 1243 | 0.34 | Why? |
| Lymphocytic choriomeningitis virus | 2 | 2017 | 98 | 0.34 | Why? |
| Genetic Variation | 2 | 2020 | 3919 | 0.33 | Why? |
| Longitudinal Studies | 6 | 2021 | 9893 | 0.33 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.32 | Why? |
| Piperazines | 3 | 2018 | 445 | 0.32 | Why? |
| Family | 1 | 2020 | 2909 | 0.31 | Why? |
| Hepatitis B Antigens | 1 | 2005 | 19 | 0.31 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.29 | Why? |
| Allografts | 2 | 2020 | 761 | 0.29 | Why? |
| Brain | 6 | 2021 | 5133 | 0.28 | Why? |
| Immunocompromised Host | 2 | 2020 | 5150 | 0.27 | Why? |
| Genotype | 8 | 2020 | 4697 | 0.27 | Why? |
| Pyridones | 3 | 2018 | 738 | 0.26 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.26 | Why? |
| Middle Aged | 35 | 2021 | 270681 | 0.25 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.25 | Why? |
| Female | 40 | 2021 | 380317 | 0.22 | Why? |
| Male | 37 | 2021 | 367725 | 0.22 | Why? |
| HIV Integrase | 2 | 2018 | 67 | 0.22 | Why? |
| Prospective Studies | 8 | 2021 | 43301 | 0.21 | Why? |
| Aged | 25 | 2021 | 215776 | 0.21 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.20 | Why? |
| Humans | 60 | 2021 | 930598 | 0.19 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.19 | Why? |
| Adult | 24 | 2021 | 244371 | 0.19 | Why? |
| HIV Envelope Protein gp120 | 2 | 2018 | 267 | 0.19 | Why? |
| Abatacept | 1 | 2020 | 192 | 0.18 | Why? |
| Genotyping Techniques | 2 | 2018 | 360 | 0.18 | Why? |
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 55 | 0.18 | Why? |
| Hepatitis B, Chronic | 1 | 2005 | 616 | 0.18 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.17 | Why? |
| Human T-lymphotropic virus 1 | 1 | 2017 | 52 | 0.17 | Why? |
| Sequence Analysis, DNA | 4 | 2020 | 2830 | 0.17 | Why? |
| Rilpivirine | 1 | 2017 | 65 | 0.17 | Why? |
| HLA-C Antigens | 1 | 2018 | 195 | 0.17 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.16 | Why? |
| Transplant Recipients | 6 | 2021 | 4982 | 0.15 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.15 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.15 | Why? |
| Cerebrospinal Fluid | 1 | 2017 | 234 | 0.15 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.15 | Why? |
| Hodgkin Disease | 1 | 2018 | 204 | 0.15 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.15 | Why? |
| Antiretroviral Therapy, Highly Active | 2 | 2018 | 952 | 0.15 | Why? |
| Serum | 1 | 2017 | 294 | 0.15 | Why? |
| False Positive Reactions | 2 | 2018 | 1338 | 0.14 | Why? |
| Magnetic Resonance Imaging | 6 | 2021 | 6551 | 0.14 | Why? |
| Urine | 1 | 2017 | 469 | 0.14 | Why? |
| Immunologic Tests | 1 | 2017 | 445 | 0.14 | Why? |
| Students, Pharmacy | 1 | 2017 | 174 | 0.13 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.13 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.13 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.13 | Why? |
| Ultrasonography, Prenatal | 1 | 2017 | 471 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.13 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.12 | Why? |
| Cytomegalovirus Infections | 1 | 2019 | 667 | 0.12 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.12 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.11 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.11 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2018 | 830 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.11 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.10 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.10 | Why? |
| Mothers | 1 | 2020 | 1624 | 0.10 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.10 | Why? |
| Polymerase Chain Reaction | 3 | 2020 | 6740 | 0.10 | Why? |
| CD3 Complex | 1 | 2009 | 237 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Confusion | 2 | 2020 | 256 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Premature Birth | 1 | 2020 | 2151 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.09 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.09 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.08 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.08 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.08 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.08 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| HIV Seropositivity | 2 | 2019 | 320 | 0.08 | Why? |
| Stroke | 2 | 2020 | 8839 | 0.08 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Graft Survival | 1 | 2009 | 587 | 0.08 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.08 | Why? |
| Blood-Brain Barrier | 2 | 2021 | 531 | 0.08 | Why? |
| RNA, Viral | 5 | 2020 | 32276 | 0.08 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.08 | Why? |
| Herpesvirus 4, Human | 1 | 2009 | 387 | 0.08 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.08 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.08 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.07 | Why? |
| Epstein-Barr Virus Infections | 1 | 2009 | 366 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.06 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.06 | Why? |
| Blood Donors | 1 | 2017 | 2956 | 0.06 | Why? |
| Organ Transplantation | 1 | 2018 | 2616 | 0.06 | Why? |
| CD4 Lymphocyte Count | 2 | 2019 | 1517 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Pregnancy Complications, Infectious | 2 | 2020 | 11559 | 0.06 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.06 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.06 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Treatment Failure | 2 | 2019 | 2106 | 0.06 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.06 | Why? |
| Renal Replacement Therapy | 2 | 2021 | 1530 | 0.06 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.06 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.06 | Why? |
| Infant Food | 1 | 2020 | 39 | 0.05 | Why? |
| Pyramidal Tracts | 1 | 2020 | 66 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Adrenergic beta-Agonists | 1 | 2020 | 93 | 0.05 | Why? |
| Gadolinium | 1 | 2021 | 318 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Viruses | 1 | 2013 | 2238 | 0.05 | Why? |
| Switzerland | 2 | 2018 | 2738 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| JC Virus | 1 | 2018 | 39 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.05 | Why? |
| Meningitis | 1 | 2020 | 163 | 0.05 | Why? |
| Psychomotor Agitation | 1 | 2020 | 208 | 0.05 | Why? |
| Brain Edema | 1 | 2020 | 224 | 0.05 | Why? |
| Abortion, Eugenic | 1 | 2017 | 14 | 0.05 | Why? |
| Mycophenolic Acid | 1 | 2020 | 383 | 0.04 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Hepatitis B virus | 1 | 2005 | 882 | 0.04 | Why? |
| Students, Medical | 1 | 2017 | 4032 | 0.04 | Why? |
| Consciousness Disorders | 1 | 2020 | 335 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| HIV Reverse Transcriptase | 1 | 2017 | 104 | 0.04 | Why? |
| Immunosuppressive Agents | 3 | 2021 | 6331 | 0.04 | Why? |
| HIV Protease | 1 | 2017 | 86 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Abortion, Legal | 1 | 2017 | 67 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Cyclosporine | 1 | 2020 | 449 | 0.04 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.04 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2017 | 309 | 0.04 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.04 | Why? |
| Contrast Media | 1 | 2021 | 1011 | 0.04 | Why? |
| Abortion, Spontaneous | 1 | 2020 | 776 | 0.03 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.03 | Why? |
| Fetus | 1 | 2017 | 484 | 0.03 | Why? |
| Monitoring, Physiologic | 1 | 2005 | 1956 | 0.03 | Why? |
| Child | 3 | 2020 | 70012 | 0.03 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Coinfection | 1 | 2013 | 6820 | 0.03 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.03 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.03 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.03 | Why? |
| Respiratory Tract Infections | 1 | 2013 | 6817 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.03 | Why? |
| Troponin I | 1 | 2021 | 1298 | 0.03 | Why? |
| Acute Disease | 1 | 2005 | 6029 | 0.03 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.03 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.03 | Why? |
| Pregnancy | 3 | 2020 | 23879 | 0.03 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.03 | Why? |
| Genes, Viral | 1 | 2017 | 1428 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Antibodies, Monoclonal | 1 | 2009 | 8041 | 0.03 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.03 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.02 | Why? |
| Cesarean Section | 1 | 2020 | 2089 | 0.02 | Why? |
| Sexual and Gender Minorities | 1 | 2020 | 1019 | 0.02 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.02 | Why? |
| Palatine Tonsil | 1 | 2009 | 127 | 0.02 | Why? |
| Pregnancy Complications | 1 | 2020 | 1388 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Hydrocortisone | 1 | 2018 | 1790 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2020 | 3803 | 0.02 | Why? |
| Placebos | 1 | 2009 | 629 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2020 | 3691 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Virus Activation | 1 | 2009 | 480 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.02 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.02 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.01 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.01 | Why? |
| Flow Cytometry | 1 | 2009 | 2393 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.01 | Why? |
| Phenotype | 1 | 2009 | 4037 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2009 | 1969 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Infant | 1 | 2013 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2013 | 36283 | 0.01 | Why? |